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Abstract We have improved the productivity of an Escherichia
coli cell-free protein synthesis system. First, creatine phosphate
and creatine kinase were used as the energy source regeneration
system, and the other components of the reaction mixture were
optimized. Second, the E. coli S30 cell extract was condensed by
dialysis against a polyethylene glycol solution to increase the rate
of synthesis. Third, during the protein synthesis, the reaction
mixture was dialyzed against a low-molecular-weight substrate
solution to prolong the reaction. Thus, the yield of chloramphe-
nicol acetyltransferase was raised to 6 mg/ml of reaction
mixture. Stable-isotope labeling of a protein with 13C/15N-
labeled amino acids for NMR spectroscopy was achieved by this
method.
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1. Introduction
Biochemical and biophysical studies of proteins usually re-
quire large-scale preparations of the proteins of interest. A
number of unnatural amino acids have been incorporated
site-speci¢cally into proteins by the chemical acylation meth-
od [1]. Moreover, speci¢cally stable-isotope-labeled proteins
for Fourier transform infrared [2] and NMR [3,4] analyses
can be produced. It is also expected that challenging proteins,
such those prone to aggregation or with toxic properties, can
be expressed by a cell-free system. Despite these merits, the
low productivity of cell-free protein synthesis systems has lim-
ited their application. Many attempts to improve the produc-
tivity have been made, mainly for the Escherichia coli and
wheat germ systems. First, the duration of the reaction has
been increased by substrate supplementation during protein
synthesis, by methods such as the continuous-£ow method
[5]. Recently, a semi-continuous £ow system using a dialysis
chamber [6] and a conventional dialysis system using a dis-
posable dialyzer [7] have been reported. Second, the rate of
protein synthesis has been increased by the use of condensed
cell extract. The condensation was achieved by ultra¢ltration
[8,9] or polyethylene glycol (PEG) precipitation [10]. In addi-
tion to these improvements, optimization of the reaction con-
ditions was reported [9,11,12]. Thus, it has been established
that about 1 mg of protein can be produced per ml of E. coli
cell-free reaction mixture [6].
In this study, we have improved the productivity of the E.
coli coupled transcription-translation cell-free protein synthe-
sis system. First, the energy source regeneration system was
changed, and the other components were optimized. Second,
the E. coli cell extract was condensed by dialysis against a
PEG-containing solution. Third, this improved cell-free sys-
tem was applied to protein synthesis with a disposable dia-
lyzer [7]. As a result, about 6 mg of chloramphenicol acetyl-
transferase (CAT) protein was synthesized per ml of the
reaction mixture in 21 h. Moreover, we applied the improved
cell-free system with dialysis for the production of a 13C/15N-
labeled Ras protein for NMR spectroscopy, by using a labeled
algal amino acid mixture, and successfully measured the
HSQC spectrum.
2. Materials and methods
2.1. Template DNA for cell-free protein synthesis
Plasmids pK7-CAT [9] and pK7-Ras [3], which have the T7 pro-
moter and the gene for the CAT protein and the human c-Ha-Ras
protein, respectively, were used as the DNA templates. The Ras pro-
tein used in this study consisted of 171 amino acid residues, and
lacked the C-terminal 18 amino acid residues, which is a better
NMR sample than the full-length form [13^16]. The truncated Ras
protein has been shown to have the same guanine-nucleotide binding
and GTPase activities, and the same NMR chemical shifts and nu-
clear Overhauser e¡ects for the corresponding residues, as the full-
length Ras protein [13,14].
2.2. Reaction conditions for the batch system
The E. coli S30 cell extract used for the cell-free protein synthesis
was prepared according to Pratt [17] from E. coli strain A19 (metB,
rna). The T7 RNA polymerase was prepared according to Zawadzki
and Gross [18]. Acetyl phosphate (AP) was purchased from Kohjin,
and acetyl kinase (AK) was from Boehringer-Mannheim. The system
used as the starting point of our study (the ‘initial’ system [3]) con-
sisted of (per 15 Wl) 55 mM HEPES-KOH (pH 7.5), 1.7 mM DTT,
1.2 mM ATP, 0.8 mM each of CTP, GTP, and UTP, 27 mM phos-
phoenolpyruvate (PEP) (Boehringer-Mannheim), 2.0% polyethylene
glycol (PEG) 8000 (Sigma), 0.64 mM 3P,5P-cyclic AMP, 68 WM
L(3)-5-formyl-5,6,7,8-tetrahydrofolic acid, 175 Wg/ml E. coli total
tRNA (Boehringer-Mannheim), 210 mM potassium glutamate,
27.5 mM ammonium acetate, 13.3 mM magnesium acetate, 0.46 mM
L-[14C]leucine (267 MBq/mmol, Amersham), 0.5 mM of each of the
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other 19 amino acids, 6.7 Wg/ml of either the pK7-Ras plasmid for Ras
expression or the pK7-CAT plasmid for CAT expression, 93 Wg/ml
T7 RNA polymerase, and 3.6 Wl S30 extract [3]. On the other hand,
the ‘improved’ system consisted of (per 15 Wl) 55 mM HEPES-KOH
(pH 7.5), 1.7 mM DTT, 1.2 mM ATP, 0.8 mM each of CTP, GTP,
and UTP, 80 mM creatine phosphate (CP) (Boehringer-Mannheim),
250 Wg/ml creatine kinase (CK) (Boehringer-Mannheim), 4.0% PEG
8000, 0.64 mM 3P,5P-cyclic AMP, 68 WM L(3)-5-formyl-5,6,7,8-tetra-
hydrofolic acid, 175 Wg/ml E. coli total tRNA, 210 mM potassium
glutamate, 27.5 mM ammonium acetate, 10.7 mM magnesium acetate,
0.64 mM L-[14C]leucine (193 MBq/mmol, Amersham), 1.0 mM of each
of the other 19 amino acids, 6.7 Wg/ml of either the pK7-Ras plasmid
for Ras expression or the pK7-CAT plasmid for CAT expression,
93 Wg/ml T7 RNA polymerase, and 4.5 Wl S30 extract. The reaction
mixture was incubated at 37‡C for 1 h.
2.3. Condensation of S30 extract
The S30 cell extract was placed in a dialysis tube (Spectra/Por,
molecular weight cut o¡ (MWCO) 12 000^14 000), and was dialyzed
against 10 volumes of an equal-weight mixture of PEG 8000 (Sigma)
and the S30 dialysis bu¡er (10 mM Tris-acetate (pH 8.2), 14 mM
magnesium acetate, 60 mM potassium acetate, and 1 mM DTT) in
a Heat Seal Bag (Yamamoto) for 45 min at 4‡C on a rotator. Then,
the S30 extract was dialyzed against 100 volumes of the S30 dialysis
bu¡er for 15 min at 4‡C. Typically, the protein was condensed 2^2.5-
fold.
2.4. Reaction conditions for the dialysis system
The reaction unit was constructed according to Davis et al. [7] using
a DispoDialyzerCE (1 ml, MWCO 10 000 or 50 000, Spectra/Por). The
internal solution (300 Wl) consisted of the same components used for
the improved batch system, 0.05% sodium azide, and 0.5 U/Wl RNase
Inhibitor (Toyobo). The external solution (3 ml) contained the com-
ponents of the internal solution except for the creatine kinase, the
plasmid vector, the T7 RNA polymerase, the S30 extract, and the
RNase inhibitor, and also contained an additional 4.2 mM magnesi-
um acetate corresponding to the magnesium carry over from the S30
extract. The reaction unit was incubated at 37‡C with shaking at
160 rpm.
2.5. Assay for reaction products
The incorporation of L-[14C]leucine into the Ras protein was deter-
mined by liquid scintillation counting of the trichloroacetic acid-in-
soluble material. The amount of CAT protein was determined by a
colorimetric assay as described [19]. The reaction products were also
analyzed by a modi¢ed SDS-PAGE [20,21].
2.6. Synthesis of 13C/15N-labeled Ras protein and NMR analysis
The reaction was carried out using three units of the dialysis system
(each unit contained 500 Wl of the internal solution and 5 ml of the
external solution) with the condensed S30 extract. The amino acids in
the internal and external solutions were replaced by 3 mg/ml of the
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Fig. 1. Improvements of the E. coli cell-free system. A: Time courses of CAT synthesis using the system with PEP-PK (a) and the system with
CP-CK (b). B: Dependence of CAT synthesis on PEG 8000 concentration (¢lled bars, 2.0%; hatched bars, 4.0%; open bars, 6.0%) at di¡erent
magnesium ion concentrations. The incubation time was 1 h. C: Time courses of Ras synthesis by the ‘initial’ (a) and the ‘improved’ (F) cell-
free systems.
Fig. 2. Time courses of Ras synthesis by the ‘improved’ cell-free sys-
tems with original S30 cell extract (F) and the condensed S30 cell
extract (W).
Fig. 3. Dependence of CAT synthesis on the concentration of the
S30 extract and the MWCO of the dialysis membrane (¢lled bars,
batch system with original S30; hatched bars, MWCO 10 kDa with
original S30; open bars, MWCO 10 kDa with condensed S30; dot-
ted bars, MWCO 50 kDa with original S30; checked bars, MWCO
50 kDa with condensed S30).
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13C/15N-labeled algal amino acid mixture (Chlorella Industries Inc.)
supplemented with 1 mM each of L-[13C,15N]phenylalanine and
L-[13C,15N]arginine, and with 1 mM each of L-cysteine, L-glutamine,
and L-asparagine. The reaction tubes were incubated at 37‡C for 4 h.
For comparison, the Ras protein was also synthesized in vivo in E.
coli cells as described [16]. The two samples of the Ras protein were
puri¢ed and sampled for NMR spectroscopy, and the HSQC spectra
were recorded as described [3] except for the pH value (= 6.5 in the
present study). As the recombinant Ras protein synthesized in vivo
retains the N-terminal Met residue, the present Ras protein synthe-
sized in the cell-free system was shown to have the terminal Met
residue by Edman sequencing (data not shown).
3. Results and discussion
3.1. Improvement of the productivity of the E. coli cell-free
batch system
During the experiments to optimize the ‘initial’ system, we
found that PEP, which was used to regenerate the energy
sources, such as ATP and GTP, in the E. coli cell-free system,
and/or a derivative of PEP, had an inhibitory e¡ect on the
system (data not shown). Therefore, instead of using the PEP-
PK energy source regenerating system, we examined the AP-
AK energy source regenerating system, which enhanced the
cell-free protein synthesis over that with PEP-PK [11]. The
system with AP-AK (40 mM and 870 Wg/ml, respectively,
were optimal) was twice as productive as the system with
PEP-PK for CAT expression (data not shown). The CP-CK
system, which is usually used in eukaryotic cell-free systems
[22], was also examined. The cell-free system with CP-CK (80
mM and 250 Wg/ml, respectively) gave maximum productivity,
and was about 2.5-fold more productive than the system with
PEP-PK for CAT expression (Fig. 1A). As the cell-free system
with CP-CK was more productive than the system with AP-
AK, CP-CK was used in the ‘improved’ system.
As previously demonstrated by our group [9], the optimal
concentrations of PEG and magnesium ion were interdepend-
ent. Thus, these concentrations were co-optimized (4.0% PEG
and 10.7 mM magnesium acetate were optimal), which in-
creased the CAT expression by about 1.5-fold (Fig. 1B). Fur-
thermore, the volume of the extract used for the cell-free re-
action was increased from 3.6 Wl/15 Wl reaction to 4.5 Wl/15 Wl
reaction, and the concentration of the amino acids was in-
creased from 0.5 mM to 1 mM.
Finally, we compared the system with the newly developed
conditions (the ‘improved’ system, see Section 2) to the system
with the previously developed conditions (the ‘initial’ system)
[3] for Ras expression. The ‘improved’ system was approxi-
mately 4-fold more productive than the ‘initial’ system, and
could synthesize more than 0.4 mg of the Ras protein per ml
reaction mixture (Fig. 1C).
3.2. Condensation of S30 extract and dialysis system
In our system, condensation with PEG precipitation [8] did
not work well, because of the di⁄culty in dissolving the pre-
cipitate, while the reproducibility of condensation with ultra-
¢ltration was not so amenable to being scaled up because of
membrane clogging. Therefore, we adopted condensation by
dialysis against a PEG-containing solution. This method is
simple and can easily be scaled up. The condensed S30 extract
appreciably increased both the initial rate of protein synthesis
and the total amount of synthesized Ras protein (Fig. 2).
3.3. Dialysis system
By the use of the dialysis system, the amount of synthesized
CAT protein was dramatically increased, and the productivity
of the dialysis system was dependent on the concentration of
the S30 extract and the MWCO of the dialysis membrane
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Fig. 4. A: Time courses of CAT synthesis by the ‘improved’ cell-free batch system (F) and the dialysis system with the condensed S30 cell
extract (R). B: SDS-PAGE analysis of the reaction products of the dialysis system with the condensed S30 cell extract (modi¢ed CBB staining
[23]).
Fig. 5. Time courses of CAT synthesis by the dialysis system using
the condensed S30 extract without an exchange of the external solu-
tion (R) and with an exchange at 6 h (E).
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(Fig. 3). The condensed S30 extract increased the productivity
of the CAT protein about 2-fold with 10 kDa and 50 kDa
MWCO membrane after 6 h of incubation. The MWCO of
the dialysis membrane strongly a¡ected the production of the
CAT protein. The amount of CAT protein synthesized with
the 50 kDa MWCO membrane was about 3.5 times greater
than that with the 10 kDa MWCO membrane, in both the
original and condensed S30 extracts. With the 10 kDa
MWCO membrane, the exchange of substrate seemed to be
insu⁄cient, due to membrane clogging. With the combination
of the condensed S30 extract and the 50 kDa MWCO mem-
brane, the concentration of the synthesized CAT protein
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Fig. 6. The 15N-HSQC spectra of the labeled Ras proteins. The backbone amide resonances and the folded sidechain amino resonances are ob-
served. A: The Ras protein synthesized by the cell-free dialysis system with the [13C,15N]algal amino acid mixture. B: The Ras protein synthe-
sized by conventional overexpression in vivo with 13C-glucose and 15N-ammonium chloride.
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reached over 3 mg/ml in the reaction mixture. The translation
kinetics of the dialysis system with the condensed S30 extract
and 50 kDa MWCO membrane indicates that a high produc-
tion rate was sustained for 6 h (Fig. 4A). The synthesized
CAT protein was observed as a thick, major band in the
SDS-PAGE analysis (Fig. 4B). The concentration of CAT
protein in the external solution after 6 h of incubation was
16 Wg/ml, and most of the CAT protein (MW 25 634) was
retained in the internal solution, in spite of the 50 kDa
MWCO. Finally, about 6 mg of the CAT protein was synthe-
sized per ml of the reaction mixture in 21 h, by an exchange of
the external solution (and supplementation of the plasmid
vector and the T7 RNA polymerase) at 6 h (Fig. 5).
The amount of the CAT protein synthesized by the dialysis
system with the condensed S30 extract and the 50 kDa
MWCO membrane (6 mg/ml) was about 10 times larger
than that with the batch system and with the 1 h incubation.
The ratio of the product to the substrate in the dialysis system
was comparable to that in the batch system. On the other
hand, 1 Wl of the original S30 extract (before condensation)
produces about 1 Wg of CAT protein in the batch system and
about 10 Wg in the dialysis system. The higher purity of the
product in the reaction mixture with the dialysis system is
advantageous for puri¢cation of the product protein.
The high productivity of our cell-free protein synthesis sys-
tem is comparable to the productivity of the in vivo expres-
sion methods. Thus, cell-free protein synthesis will become a
powerful protein production method for biochemistry and
biophysics.
3.4. 13C/15N-labeled Ras protein
In order to produce a 13C/15N-labeled Ras protein by the
cell-free system, we used 13C/15N-labeled algal amino acid
mixture instead of unlabeled amino acids in the reaction mix-
ture. The algal amino acid mixture contained no cysteine,
glutamine, asparagine, and tryptophan, and only small
amounts of tyrosine, phenylalanine, and arginine. Therefore,
these amino acids, except tryptophan, which is not contained
in the Ras protein, were supplemented. Second, the potassium
glutamate contained in the original reaction mixture was elim-
inated, because it interferes with the labeling of the glutamate
residues of the Ras protein, and the other salt concentrations
were optimized to eliminate the potassium glutamate. These
modi¢cations did not decrease the production of the Ras pro-
tein (data not shown).
The 15N-HSQC spectrum of the labeled Ras protein synthe-
sized in vitro was consistent with that of the uniformly labeled
protein synthesized in vivo (Fig. 6). The 13C-HSQC spectra
were also measured successfully (data not shown). All of the
observed backbone amide 15N resonances for the amino acid
residues, which had originally been labeled amino acids in the
reaction mixture, were successfully assigned according to the
resonance assignment for the uniformly labeled recombinant
Ras (Fig. 6), indicating that the in vitro and in vivo prepara-
tions of the Ras protein have the same tertiary structure. As
unlabeled L-glutamine, L-asparagine, and L-cysteine were used
in the cell-free synthesis, the backbone amide resonances of
the Asn and Cys residues and the side chain resonances of the
Gln and Asn residues were missing, while the backbone amide
resonances of the Gln residues were very weakly observed
probably because of metabolic conversion of L-glutamate to
L-glutamine (Fig. 6). In addition, the amide resonances of the
Glu and Asp residues were somewhat weakened probably by
metabolic dilution of stable isotopes. If all of the amino acids,
including L-glutamine and L-asparagine, in the cell-free pro-
tein synthesis are labeled with stable isotopes, the Ras protein
may be labeled uniformly. Therefore, cell-free protein synthe-
sis will become a powerful protein production method for
NMR spectroscopy.
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